A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study)
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2019
At a glance
- Drugs KD 025 (Primary)
- Indications Graft-versus-host disease
- Focus Registrational; Therapeutic Use
- Acronyms ROCKstar Study
- Sponsors Kadmon Holdings
- 25 Oct 2018 According to a Kadmon Holdings media release, first patient has been dosed in the trial.
- 17 Oct 2018 Status changed from not yet recruiting to recruiting, according to a Kadmon Holdings media release.
- 17 Aug 2018 Status changed from planning to not yet recruiting.